Turtle Cameron bought SYRE
January 9, 2026 · Form 4 insider transaction
Turtle Cameron bought 528,000 shares of Spyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
528,000
Price
$0.00
Total value
N/A
InsiderTurtle Cameron
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after528,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase 528,000 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.